Pharmaceutical Development - Unibest Industrial Co., Ltd.

Blogs

Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

10 Key Considerations for Mastering Active Pharmaceutical Ingredient Procurement: A Unibest Perspective
2024-08-20

At Unibest, we're proud to be the go-to partner for global pharmaceutical companies seeking high-quality active pharmaceutical ingredients (APIs). Our unmatched expertise in sourcing top-tier pharmaceutical ingredients sets us apart. Today, we're sharing our insights on identifying and selecting the Read More
5 Benefits of Deuteration in Drug Discovery
2024-07-31

In the recent advancement of pharmaceutical research and development, deuteration has emerged as a powerful tool for enhancing drug properties and creating new opportunities for innovative drug companies. This blog post explores the potential of deuteration and its impact on the pharmaceutical indus Read More
Cardiovascular Benefits of Semaglutide - Clinical Trial Interpretation
2024-07-23

A recent study published in the international journal Diabetes Care, titled "Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT," has revealed a new benefit of Semaglutide - the cardiovascular benefits. Read More
Semagcare - Semaglutide Tablets Distributor & FDF Development
2024-07-15

Unibest proudly partners with a renowned supplier to bring you Semagcare, a premium product line featuring in-housed developed Semaglutide API and Semaglutide tablets available in 3mg, 7mg, and 14mg dosages.Key FeaturesSemagcare: High-quality Semaglutide tablets intended for diabetes and obesity tre Read More
Groundbreaking HIV Prevention Drug Shows 100% Efficacy in Phase 3 Trial
2024-06-24

A recent Phase 3 clinical trial (NCT04994509), dubbed "PURPOSE 1," has yielded promising results for a new HIV prevention drug, potentially revolutionizing the field of HIV prophylaxis. The study, conducted by Gilead Sciences, evaluated the safety and efficacy of Lenacapavir, a novel long-acting HIV Read More
The Complement System: A Frontier in Drug Development
2024-06-12

The complement system has long been recognized as a crucial component of the innate immune system, acting as the first line of defense against invading pathogens. However, recent advancements in understanding this intricate network have unveiled its multifaceted roles in various physiological proces Read More
Tirzepatide Approved by NMPA for Type II Diabetes
2024-05-21

On May 21st, the Chinese National Medical Products Administration (NMPA) approved Tirzepatide (brand name Mounjaro), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Lilly, for the improvement of glycemic control in adults wi Read More
Case Study of Flow Chemistry in the Synthesis of Pharmaceutical Ingredient Belzutifan
2024-04-23

IntroductionIn a previous article, we discussed when to consider using flow chemistry over conventional batch processes for chemical synthesis. One compelling example highlighting the advantages of flow chemistry comes from the manufacturing route development for belzutifan, a recently approved drug Read More
Scaling the Everest of Pharma Synthesis: A Deep Dive into Eribulin's Journey
2024-04-19

As one steps into the realm of pharmaceutical discovery, the name Eribulin, also known as Halaven, rings a powerful note. First approved in 2010 by Eisai, this non-peptide drug, intricate in its synthesis and impressive in the magnitude of its medical impact, has been nothing short of groundbreaking Read More